VHPB Centre for Evaluation of Vaccination (CEV) |
Executive Secretary Administrative and Scientific Secretariat |
privacy statement
|
June 01-02, 2017 - Vienna, Austria
Meeting objectives:
Background document - 2.9 Mb (.pdf)
Thursday 01 June
SESSION 1: OPENING AND OBJECTIVES
Chairs: John Ward and Paolo Bonanni
08:30-09:00
SESSION 2: INTRODUCTION PERINATAL TRANSMISSION
09:00 - 09:20 Introduction of Perinatal transmission of hepatitis B - 552 kb (.pdf)
Noele Nelson
09:20 - 09:40 Perinatal HBV viremia in newborns of HBsAg(+) mothers is a transient phenomenon that does not necessarily imply HBV infection transmission - 1.8 Mb (.pdf)
Vana Papaevangelou
09:40 - 10:00 Perinatal transmission of hepatitis C virus - 3.4 Mb (.pdf)
Giuseppe Indolfi
10:00 - 10:20 Questions and discussion
SESSION 3: IS PERINATAL TRANSMISSION (STILL) AN ISSUE FOR THE ELIMINATION OF VIRAL HEPATITIS
Chairs: Vladimir Chulonov and Erika Duffell
10:40 - 11:00 Perinatal transmission of hepatitis B virus during pregnancy and delivery in Denmark - 788 kb (.pdf)
Nina Weis
11:00- 11:20 Outcomes of infants born to women infected with hepatitis B AND Characteristics of Pregnant Women With Hepatitis B Virus Infection in 5 US Public Health Jurisdictions, 2008-2012 - 424 kb (.pdf)
Sarah Schillie
11:20- 11:40 Mother-to-child transmission of hepatitis B in sub-Saharan Africa - 1.1Mb (.pdf)
Yusuke Shimakawa
11:40 - 12:00 Mother to child transmission, in Asia and Latin America (PAHO) - 2.7 Mb (.pdf)
Nick Walsh
12:00- 12:20 Viral hepatitis in pregnant women in England: results from two surveillance studies - 478 kb (.pdf)
Heather Bailey
12:20 - 12:40 Discussion
12:40 – 13:45 Lunch
SESSION 4: PERINATAL TRANSMISSION RISK FACTORS
Chairs: Alessandro Zanetti and Françoise Roudot-Thoraval
13:45 - 14:05 The Effect of Genotype/Subgenotype of Hepatitis B Virus on HBeAg Expression and Perinatal Transmission - 3.6 Mb (.pdf)
Anna Kramvis
14:05 - 14:25 Vertically acquired hepatitis C virus infection: Correlates of transmission and disease progression - 2.1 Mb (.pdf)
Silvia Garazzino
14:25 - 14:45 Increased Hepatitis C Virus (HCV) Detection in Women of Childbearing Age and Potential Risk for Vertical Transmission - United States and Kentucky, 2011-2014 - 554 kb (.pdf)
Noele Nelson
14:45 - 15:05 Questions & Comments
15:05- 15:30 Coffee break
SESSION 5: PREVENTION
Chairs: Mojca Maticic and Rui Tato Marinho
15:30 - 15:50 Antenatal screening for hepatitis C: Universal or risk factor based? - 0.4 Mb (.pdf)
Nazha Abughali
15:50 - 16:10 Questions & comments
16:10 - 16:30 Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland - 1 Mb (.pdf)
Karoline Aebi-Popp
16:30 - 16:50 Should we treat hepatitis B positive pregnant women to prevent MTCT? - 1.9 Mb (.pdf)
Daniel Shouval
16:50 – 17:10 Questions & comments
17:10- 17:30 Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection Shortened Interval for Post vaccination Serologic Testing of Infants Born to Hepatitis B-Infected Mothers - 487 kb (.pdf)
Sarah Schillie
17:30- 17:50 Hepatitis B vaccine alone or with hepatitis B immunoglobulin in neonates of HBsAg+/HBeAg- mothers: a systematic review and meta-analysis Adherence to perinatal hepatitis B prevention programmes - 1 Mb (.pdf)
Vana Papaevangelou
17:50 – 17:10 Questions
Friday 02 June
SESSION 5: PREVENTION (continued)
Chairs: Daniel Shouval and Fiona Godfrey
08:30 – 08:50 Control of perinatal HBV infection: WHO approach from success with timely birth dose to future perspectives in the context of triple elimination
Yvan Hutin
08:50 – 09:10 Questions & Comments
Session 6: POLICY RECOMMENDATIONS FOR PREVENTION OF PERINATAL TRANSMISSION
09:10– 10:10 Overview of existing guidelines and/or activities to prevent MTCT
10:10- 10:35 How Should Evidence-Based Medicine Be Used to Design Clinical Practice Guidelines for the Prevention of Perinatal Transmission of HBV From HBeAg-Positive Mothers?
Blaine Hollinger
10:35 – 10:40 Question and discussion
SESSION 7: WORKSHOP DISCUSSION
Chairs: Mark Kane – Pierre Van Damme
10:40 – 12:30 Workshop discussions: Identify challenges and objectives to improve perinatal transmission and secure the success of the elimination goals by 2030
12:30 – 13:30 Presentation Workshop conclusion
12:40 – 13:45 Lunch
SESSION 8: CONCLUSIONS
Chairs: Daniel Lavanchy and Liudmila Mosina
14:30 – 15:30 Presentation of the VHPB meeting conclusions by the rapporteur.
David FitzSimons
MEETING REPORT ON PERINATAL TRANSMISSION by David FitzSimons (Pdf, 647 kB)